In addition, he received localized external beam radial therapy and chemotherapy prior to his esophagectomy, at which time he had received a Port-A-Cath in [**2150-12-17**].
MRA showed this to be a 3x3 cm mass that enhances, therefore, had a high likelihood of renal cell carcinoma.
He has had Port-A-Cath placement and an exploratory laparotomy to rule out metastatic disease.
Zantac 75 mg twice day  ADMISSION PHYSICAL EXAM: VITAL SIGNS:  Pulse 76, blood pressure 120/70, respiratory rate 18 with 96% room air saturation.
He was afebrile with a temperature of 98.7??????
HEAD, EARS, EYES, NOSE AND THROAT:  Unremarkable.
LUNGS:  Clear to auscultation bilaterally.
SIGNIFICANT PREOPERATIVE LABS:  Hematocrit 25%, BUN and creatinine of 34 and 0.7.
X-RAYS:  He had a CT and MRI that showed a 3 cm right upper pole mass, stable over the last seven months.
Vitals were otherwise stable.
Postoperative hematocrit was 25.3, white count 13.3, platelet count 300.
Chest x-ray postoperatively showed no evidence of pneumothorax.
He was encouraged to ambulate the following day and his hematocrit was followed serially.
Blood pressure was stable at 100 systolic.
Follow up chest x-ray showed no evidence of pneumothorax.
Hematocrit continued to be stable.
He was just given arm elevation and his right subclavian Port-A-Cath was removed on postoperative day #3 by Dr.[**Name (NI) 1482**] service.
His discharge INR was 1.2 with a PTT of 26 and a PT of 13.
Discharge hematocrit was 28.4, platelet count 224,000.
White count was 7.5000.
BUN and creatinine were 14 and 0.9.
Final pathology is pending.
